MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202627077566 A) filed by Ascletis Pharma China Co. , Limited on June 23, 2026, for Glp-1r Agonist And Therapeutic Method Thereof.
Inventors include Liang, Bin; Wu, Jinzi Jason; and Yang, Bailing.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The present disclosure describes GLP-1R modulating the compounds of Formula (I) that are useful for treating GLP-1R-mediated diseases or conditions.
Disclaimer: Curated by HT Syndication.
